ProCredit Holding AG & Co. KGaA (0RL9)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 8.850 |
|---|---|
| 52-week range | 6.548 – 9.250 |
| Return, 1 month / 3 months | −3.0% / +7.8% |
| Return, 1 year / 3 years | +1.4% / +70.0% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 32.8% |
| Worst drawdown (1 year) | -26.3% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ProCredit Holding AG & Co. KGaA is the parent company of the ProCredit group, a network of development-oriented commercial banks. The group serves small and medium-sized businesses, along with private customers, through local banks in Eastern Europe, Latin America and other emerging markets. Its banks offer business loans, savings accounts, payment services and other everyday banking products. The holding company is based in Frankfurt, Germany, and coordinates the group's strategy and operations across its member banks.
On this site ProCredit Holding AG & Co. KGaA appears as a stock on the London Exchange (UK), code 0RL9, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ProCredit Holding AG & Co. KGaA (0RL9) trades on the London Exchange in UK. It last closed at EUR 8.850 on 21 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,499 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.4% and over the last three months it rose 7.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.5% | ||
| From 52-week high | -3.0% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.8% | ||
| 6-month return | 12.0% | ||
| 12-month return, skipping the last month | 4.5% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.3% | ||
| Liquidity | 24 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −3.0% |
| 3 months | +7.8% |
| 6 months | +12.0% |
| 1 year | +1.4% |
| 3 years | +70.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.673 / 8.082 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.192 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.4700 |
| 5 Jun 2025 | EUR 0.5900 |
| 5 Jun 2024 | EUR 0.6400 |
| 9 Dec 2021 | EUR 0.3500 |
| 28 May 2021 | EUR 0.1800 |
| 20 May 2019 | EUR 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.